Login to Your Account

Biologics make some inroads, but generics still clog CFDA

By Shannon Ellis
Staff Writer

Wednesday, March 19, 2014

SHANGHAI – The Center for Drug Evaluation (CDE) of the China Food and Drug Administration (CFDA) has released its annual report for 2013 which reveals only small gains have been made to fix the slow and overcrowded approval process.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription